Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline

Journal of Human Genetics

Volumn 56, Issue 9, 2011, Pages 652-659

  Kim, Jeong Hyun ^a   Park, Byung Lae ^b   Pasaje, Charisse Flerida A ^a   Bae, Joon Seol ^a   Park, Jong Sook ^a   Park, Sung Woo ^c   Uh, Soo Taek ^c   Kim, Mi Kyeong ^d   Choi, Inseon S ^e   Cho, Sang Heon ^f   Choi, Byoung Whui ^g   Park, Choon Sik ^c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Chungbuk National University   (South Korea)

^e Chonnam National University   (South Korea)

^f Seoul National University   (South Korea)

^g Chung Ang University   (South Korea)

Author keywords

aspirin exacerbated respiratory disease (AERD); haplotype; single nucleotide polymorphism; TAP1; TAP2

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER A2; ACETYLSALICYLIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CHROMOSOME 6P; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROVOCATION TEST; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; ATP-BINDING CASSETTE TRANSPORTERS; BRONCHIAL PROVOCATION TESTS; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 80053259946     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2011.75     Document Type: Article

References (30)

1. Hedman, J., Kaprio, J., Poussa, T. & Nieminen, M. M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a populationbased study. Int. J. Epidemiol. 28, 717-722 (1999). (Pubitemid 29401332)
2. Szczeklik, A. & Stevenson, D. D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J. Allergy. Clin. Immunol. 111, 913-921; quiz 922 (2003). (Pubitemid 36570845)
3. Bel, E. H. Clinical phenotypes of asthma. Curr. Opin. Pulm. Med. 10, 44-50 (2004). (Pubitemid 38045900)
4. Babu, K. S. & Salvi, S. S. Aspirin and asthma. Chest 118, 1470-1476 (2000).
5. Koppelman, G. H., Meyers, D. A., Howard, T. D., Zheng, S. L., Hawkins, G. A., Ampleford, E. J. et al. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180, 929-935 (2009).
6. Pasaje, C. F., Kim, J. H., Park, B. L., Cheong, H. S., Chun, J. Y., Park, T. J. et al. Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Ann. Hum. Genet. 74, 326-334 (2010).
7. Alberts, P., Daumke, O., Deverson, E. V., Howard, J. C. & Knittler, M. R. Distinct functional properties of the TAP subunits coordinate the nucleotide-dependent transport cycle. Curr. Biol. 11, 242-251 (2001). (Pubitemid 32185326)
8. Gadola, S. D., Moins-Teisserenc, H. T., Trowsdale, J., Gross, W. L. & Cerundolo, V. TAP deficiency syndrome. Clin. Exp. Immunol. 121, 173-178 (2000). (Pubitemid 30659751)
9. Dogru, D., Ozbas Gerceker, F., Yalcin, E., Cobanoglu, N., Pekcan, S., Ozcelik, U. et al. The role of TAP1 and TAP2 gene polymorphism in idiopathic bronchiectasis in children. Pediatr. Pulmonol. 42, 237-241 (2007). (Pubitemid 46417696)
10. Ismail, A., Bousaffara, R., Kaziz, J., Zili, J., el Kamel, A., Tahar Sfar, M. et al. Polymorphism in transporter antigen peptides gene (TAP1) associated with atopy in Tunisians. J. Allergy Clin. Immunol. 99, 216-223 (1997).
11. Cormican, L. J., Farooque, S., Altmann, D. R. & Lee, T. H. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin. Exp. Allergy 35, 717-722 (2005). (Pubitemid 40961342)
12. Nizankowska-Mogilnicka, E., Bochenek, G., Mastalerz, L., Swierczynska, M., Picado, C., Scadding, G. et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62, 1111-1118 (2007). (Pubitemid 47374015)
13. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005). (Pubitemid 40202029)
14. Stephens, M., Smith, N. J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001). (Pubitemid 32289743)
15. Pierzchalska, M., Szabo, Z., Sanak, M., Soja, J. & Szczeklik, A. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J. Allergy Clin. Immunol. 111, 1041-1048 (2003). (Pubitemid 36570865)
16. Choi, J. H., Park, H. S., Oh, H. B., Lee, J. H., Suh, Y. J., Park, C. S. et al. Leukotrienerelated gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum. Genet. 114, 337-344 (2004).
17. Farooque, S. P. & Lee, T. H. Aspirin-sensitive respiratory disease. Annu. Rev. Physiol. 71, 465-487 (2009).
18. Shi, J., Misso, N. L., Duffy, D. L., Bradley, B., Beard, R., Thompson, P. J. et al. Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy. Eur. Respir. J. 26, 249-256 (2005). (Pubitemid 41079068)
19. Akbari, O., Faul, J. L., Hoyte, E. G., Berry, G. J., Wahlstrom, J., Kronenberg, M. et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
20. Gromme, M. & Neefjes, J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol. Immunol. 39, 181-202 (2002). (Pubitemid 35013511)
21. Kim, K. R., Cho, S. H., Choi, S. J., Jeong, J. H., Lee, S. H., Park, C. W. et al. TAP1 and TAP2 gene polymorphisms in Korean patients with allergic rhinitis. J. Korean Med. Sci. 22, 825-831 (2007).
22. Ramos, P. S., Langefeld, C. D., Bera, L. A., Gaffney, P. M., Noble, J. A. & Moser, K. L. Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC. Genes Immun. 10, 350-355 (2009).
23. Yan, G., Shi, L. & Faustman, D. Novel splicing of the human MHC-encoded peptide transporter confers unique properties. J. Immunol. 162, 852-859 (1999). (Pubitemid 29035409)
24. Momburg, F., Armandola, E. A., Post, M. & Hammerling, G. J. Residues in TAP2 peptide transporters controlling substrate specificity. J. Immunol. 156, 1756-1763 (1996). (Pubitemid 26069307)
25. Choi, J. H., Lee, K. W., Oh, H. B., Lee, K. J., Suh, Y. J., Park, C. S. et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J. Allergy Clin. Immunol. 113, 562-564 (2004). (Pubitemid 38338966)
26. Sanak, M., Simon, H. U. & Szczeklik, A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350, 1599-1600 (1997). (Pubitemid 28036609)
27. Van Sambeek, R., Stevenson, D. D., Baldasaro, M., Lam, B. K., Zhao, J., Yoshida, S. et al. 5¢ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J. Allergy Clin. Immunol. 106, 72-76 (2000). (Pubitemid 30482855)
28. Keicho, N., Tokunaga, K., Nakata, K., Taguchi, Y., Azuma, A., Tanabe, K. et al. Contribution of TAP genes to genetic predisposition for diffuse panbronchiolitis. Tissue Antigens 53, 366-373 (1999).
29. Adair-Kirk, T. L., Atkinson, J. J. & Senior, R. M. Smoke particulates stress lung cells. Nat. Med. 14, 1024-1025 (2008).
30. Malhotra, D., Thimmulappa, R., Vij, N., Navas-Acien, A., Sussan, T., Merali, S. et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am. J. Respir. Crit. Care Med. 180, 1196-1207 (2009).